Addleshaw Goddard Advises on $190 Million Minority Investment in Egypt’s Alameda Healthcare

Healthcare

Addleshaw Goddard Advises on $190 Million Minority Investment in Egypt’s Alameda Healthcare

International law firm Addleshaw Goddard has played a key advisory role in a landmark $190 million minority investment in Alameda Healthcare, Egypt’s leading private healthcare provider. The investment was led by Development Partners International (DPI), a London-based private equity firm, along with its co-investors.

Structured primarily as a capital increase, the transaction is expected to close in the third quarter of 2025, pending regulatory approvals. The deal represents the largest private equity investment in Egypt’s healthcare sector to date and marks a major step forward for both Alameda and DPI.

The capital injection will allow Alameda Healthcare to accelerate its expansion plans both within Egypt and into Gulf markets, positioning the country as a regional hub for world-class healthcare services. The funding will be used to grow Alameda’s hospital and outpatient clinic network, integrate advanced clinical technologies, and enhance its Centres of Excellence in cardiology, oncology, and liver disease.

Additionally, a portion of the investment will go toward talent development, including upskilling Egyptian healthcare professionals and reversing the sector’s brain drain by creating attractive career opportunities within the country.

Founded in 1999, Alameda operates two flagship hospital brands—As-Salam International and Dar Al Fouad—alongside a network of seven polyclinics, a rehabilitation centre, home healthcare provider Tabibi 24/7, and various diagnostic, laboratory, and pharmacy services. Notably, Alameda is the only private healthcare group in Egypt to hold Joint Commission International (JCI) accreditation across all of its hospitals, reflecting its commitment to patient care and clinical excellence.

“We are proud to have supported Alameda Healthcare on a transaction of such strategic significance,” said Philip Dowsett, Partner and Head of Investment Management and Funds at Addleshaw Goddard MENA. “DPI’s investment reflects growing global confidence in Egypt’s healthcare infrastructure and Alameda’s leadership position within it. This deal also demonstrates our ability to advise on transformative cross-border investments that deliver regional impact.”

Addleshaw Goddard acted as international legal counsel to Alameda Healthcare, providing advisory services on transaction structuring, investor negotiations, and multi-jurisdictional regulatory compliance.

This deal further highlights Addleshaw Goddard’s expertise in managing complex, high-value investments across healthcare, private equity, and emerging markets in the Middle East and Africa.